The nation of Zimbabwe has declined a major American healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' insistence on confidential information.
This rejection became public following a official document dated December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official representative has since stated that the United States was seeking health data for scientific study and commercial gain but refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for more negotiations to find a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Wider Context
This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and accountability.
According to statements, Sixteen nations in Africa have to date signed similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be available to our population if a new health crisis arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems already set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This mechanism is designed to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how future co-operation might be arranged in a way that respects the independence and dignity of each country."
Medical Community Reaction
Medical experts said it recognised the government's concerns, but suggested that negotiations need to persist since a large portion of the country's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those involving information security or agreement terms, these can often be resolved via technical clarification and negotiated safeguards," the group added.
The halted deal emphasises the complex challenges between receiving much-needed international aid and safeguarding local interests in an increasingly data-driven world.